Search
Filter Results
Displaying 251–260 of 373 results for “coins free fc 26 Visit Buyfc26coins.com Nopeat päivitykset uusista tarjouksista..bWOV”
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
“Eye of the Beholder” was initiated by two artists — both affected by retinal disease, and who are very well aware of the significance of such a contribution. For some, our artwork is an important source of income; for all, it is a deeply personal pursuit.
-
Jul 11, 2022
Eye on the Prize Winner: Josh/Nicholls State University
Beacon StoriesThis year, the Foundation created a new fundraising initiative called Eye on the Prize, influenced by March Madness. The winner of the inaugural Eye on the Prize competition was Nicholls State University, raising $2,428. This winning team was led by Josh Cogswell, an assistant professor of management at Nicholls State University, who has his own personal connection to the Foundation’s mission.
-
Jun 20, 2022
Research NewsThe newly approved drug reduces the pathologic hunger associated with BBS
-
May 23, 2022
Beacon Stories My Retina Tracker Patient StoriesMark Erelli has been a professional musician for the past twenty-three years. He’s always used songwriting to express himself. Since being diagnosed with retinitis pigmentosa, he’s needed music more than ever.
-
May 12, 2022
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
In the PressBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
-
May 10, 2022
Foundation NewsThe Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for retinal degenerative diseases, will host an online continuing medical education (CME and COPE) course on inherited retinal disease gene therapies on Thursday, June 9, 2022, at 7:00 p.m. EDT.
-
May 2, 2022
Encouraging Clinical Trial Results for Alkeus’ Stargardt Disease Treatment
Research NewsThe company is also conducting a Phase 3 clinical trial of the emerging therapy for geographic atrophy.
-
Mar 14, 2022
Advocating for the Foundation Through Professional Outreach
Beacon StoriesAs a longtime supporter and advocate for the Foundation Fighting Blindness, Lora has recently begun working with the Professional Outreach team. Lora’s work helps eye care professionals in the Philadelphia region provide vital resources for their patients with inherited retinal diseases.
-
Mar 3, 2022
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
In the PressIndustry Veteran Brings Broad Ophthalmology Research & Development Expertise.